An ROS-Responsive CeO2-Selenium Nanozyme Mitigates Renal Injury via Coordinated Ferroptosis Inhibition and Inflammation Resolution.
An engineered ROS-responsive nanozyme is developed by integrating diselenide-bridged organosilica, hyaluronic acid, hyaluronic acid (HA)-modified cerium oxide (CeO2), and a selenium-containing diselenide framework that significantly improves renal function and attenuates tissue injury, fibrosis, and inflammation.